On the morning of December 23, 2025, Hai Phong Children's Hospital officially announced a key change in its executive structure... Read more
Category: Uncategorized
Thanh Hoa Establishes Strategic Partnership to Optimize Non-Communicable Disease Management Through a Primary Healthcare Model
On December 20, 2025, the Thanh Hoa Department of Health and Servier Vietnam officially established a strategic cooperation framework by... Read more
Boehringer Ingelheim Commits $448 Million to Tackle Vascular Calcification in Kidney Disease
Boehringer Ingelheim has unveiled a strategic partnership with Rectify Pharmaceuticals to develop small-molecule therapies that enhance the function of the... Read more
Mammography AI Enhances Detection of Hidden Breast Cancer Indicators
Medical technology firm Hologic has released new experimental data strengthening the role of artificial intelligence (AI) in breast cancer screening.... Read more
Emergency Coagulant Withdrawn from U.S. Market Following Safety Concerns
As of December 22, 2025, AstraZeneca has officially ceased all production and commercial sales of Andexxa in the United States.... Read more
UK Authorizes Twice-Yearly Injectable for HIV Prevention
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has officially granted marketing authorization for lenacapavir (branded as Yeytuo) for... Read more
A New Chapter in Obesity Management: The Emergence of Oral Weight-Loss Medications
The healthcare industry has reached a significant milestone with the FDA's official approval of the tablet version of semaglutide (Wegovy).... Read more
White House Secures Pricing Accords with Nine Additional Pharmaceutical Giants
In a major step toward implementing the "Most-Favored-Nation" (MFN) pricing policy, the Trump administration has announced individual agreements with nine... Read more
AstraZeneca Inks $2 Billion Deal to Secure Next-Generation Cancer Inhibition Technology
AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more









